tm logo
SYNGENE SYNVENT
Live/Registered
REGISTERED

on 05 Apr 2022

Last Applicant/ Owned by

Bangalore 560099

Karnataka

IN

560099

Serial Number

90065058 filed on 21st Jul 2020

Registration Number

6695032 registered on 05th Apr 2022

in the Principal Register

Correspondent Address

Mark A. Watkins

VORYS, SATER, SEYMOUR AND PEASE LLP

P.O. BOX 2255

IPLAW@VORYS

COLUMBUS, OH 43216-2255

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SYNGENE SYNVENT

The mark consists of the word "SYNGENE", in a smaller font, above the right half of the word "SYNVENT", the word "SYNVENT" having the the outline of the letter "V" within a solid circle. Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services for medical and diagnostic purposes ScientRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials for scientific research for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, and solid state characterization; toxicokinetic analysis and toxicology services; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, genes, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; none of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculture, horticulture and forestry


First Use Date in General

11th Aug 2021

First Use Date in Commerce

11th Aug 2021

Class [044]
Medical, Beauty & Agricultural Services


Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services for medical and diagnostic purposes


First Use Date in General

11th Aug 2021

First Use Date in Commerce

11th Aug 2021

Mark Details


Serial Number

No 90065058

Mark Type

No Service Mark

Attorney Docket Number

No 077752-06

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.03 -

Incomplete circles (more than semi-circles)

26.01.21 -

Circles that are totally or partially shaded

27.03.01 -

Geometric figures forming letters or numerals, including punctuation

Description of Design Search

The mark consists of the word "SYNGENE", in a smaller font, above the right half of the word "SYNVENT", the word "SYNVENT" having the the outline of the letter "V" within a solid circle.

Legal History


Show more

Status DateAction Taken
05th Apr 2022REGISTERED-PRINCIPAL REGISTER
04th Mar 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03rd Mar 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15th Feb 2022STATEMENT OF USE PROCESSING COMPLETE
14th Feb 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
27th Jan 2022USE AMENDMENT FILED
27th Jan 2022TEAS STATEMENT OF USE RECEIVED
27th Jul 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01st Jun 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01st Jun 2021PUBLISHED FOR OPPOSITION